LOS ANGELES, Aug. 26, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (ARMP) ("Armata" or the "Company"), a biotechnology company focused on the development of high-purity, pathogen-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback